Trial reportEndoscopy2025
Prospective single-arm trial on feasibility and safety of an endoscopic robotic system for colonic endoscopic submucosal dissection.
Trial report in Endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Robotic-assisted endoscopic submucosal dissection for superficial gastrointestinal neoplasms: a bayesian meta-analysis & systematic review.Journal of robotic surgery · 2026Pooled it
- Global trends and hotspots in robot-assisted gastrointestinal endoscopy: a bibliometric and visualization analysis.Journal of robotic surgery · 2026Review
- Bibliometric mapping of robot-assisted endoscopic submucosal dissection: research trends, collaboration networks, and emerging themes.Journal of robotic surgery · 2026Review
- A novel bimanual endoluminal robotic platform compatible with standard gastroscopes for endoscopic submucosal dissection: preclinical feasibility and ergonomic evaluation.Surgical endoscopy · 2026Article
- Robotic-assisted endoscopic submucosal dissection: a scoping review of preclinical and early clinical evidence.Surgical endoscopy · 2026Article
- Ethical and Legal Implications of Implementing AI in Gastrointestinal Endoscopy.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026Review
- Global Evolution of Robotic Colorectal Surgery: Lessons from Hong Kong's Innovation and Implementation.Cancers · 2026Review
- [Current Status of Robotic Therapeutic Endoscopic Platforms].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2026Review
- Dual-function robotic gripper for traction and closure in gastric endoscopic submucosal dissection: an in vivo porcine model study (with video).Surgical endoscopy · 2025Article
- Artificial intelligence-based marks detection and incision guide line prediction model in esophageal endoscopic submucosal dissection: a multicenter study (with video).Surgical endoscopy · 2025Article
- Artificial Intelligence in GI endoscopy: what to expect.Frontiers in medicine · 2025Article
- Emerging endoscopic resection strategies for organ preservation in early colorectal cancer.Annals of gastroenterologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe development of the EndoMaster "Endoluminal Access Surgical Efficacy" (EASE) system aims to enhance the safety and efficacy of colonic endoscopic submucosal dissection (ESD) through two flexible robotic arms. This is the first clinical trial to evaluate the performance of colorectal ESD using EndoMaster.
methodPatients with early mucosal colorectal neoplasia that was not suitable for en bloc resection with snare-based techniques were recruited. The EndoMaster EASE robotic system consisted of an independently designed flexible robotic platform with two robotic arms. The primary outcome was the complete resection rate using EndoMaster. Secondary outcomes included operating time, hospital stay, procedure-related complications, and oncologic outcomes.
results43 patients underwent robotic ESD, with a median robotic dissection time of 49 minutes. The technical success rate was 86.0%, while en bloc resection rate among cases with technical success was 94.6%. The complete resection rate was 83.8% and the median size of specimen was 35 mm (range 15-90 mm). The median hospital stay was 2 (range 1-7) days and there was one delayed bleed after 4 days, which was controlled endoscopically. One patient sustained perforation during the procedure, which was completely closed using clips without sequelae. Two patients were treated by salvage surgery.
conclusionThis first clinical trial confirmed the safety and efficacy of performing colorectal ESD using the EndoMaster EASE robotic system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.